230 results
Page 3 of 12
8-K
EX-99.2
7oq7r1zoio20gu4
31 Aug 23
Zevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial Product
8:01am
8-K
ozascm7jbe7rvhjfk
26 Apr 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
l20vb5x2mhi jjmoc7k0
1 Jul 22
Submission of Matters to a Vote of Security Holders
8:32am
DEFA14A
sohutlarr lavqsvx
17 Jun 22
Additional proxy soliciting materials
9:17am
8-K
km7nxz01jlqx4mgz
17 Jun 22
Changes in Registrant's Certifying Accountant
9:14am
8-K
EX-10.1
jjfphreioxl2798
31 May 22
Entry into a Material Definitive Agreement
9:13pm
8-K
EX-99.1
tkyqw
16 May 22
KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline
8:40am
8-K
EX-10.1
lz8zspxkd uzv1w
16 May 22
KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline
8:40am
8-K
EX-99.2
g57coyzl
16 May 22
KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline
8:40am
8-K
EX-99.1
5awgcqu 59ud
12 May 22
KemPharm Reports First Quarter 2022 Financial Results and Corporate Updates
4:48pm